Filing metadata

Accession number
0001209191-23-009280
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Feb 14, 2023
Reporting period
Feb 10, 2021
Description
Insider transaction

Explore SEC Filings Hub